Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Docetaxel × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 108 Breast Neoplasms 104 Prostatic Neoplasms 77 Lung Neoplasms 37 Neoplasms 26 Squamous Cell Carcinoma of Head and Neck 25 Neoplasm Metastasis 24 Stomach Neoplasms 20 Esophageal Neoplasms 19 Head and Neck Neoplasms 18 Pancreatic Neoplasms 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Ovarian Neoplasms 14 Urinary Bladder Neoplasms 11 Sarcoma 9 Triple Negative Breast Neoplasms 8 Carcinoma, Transitional Cell 7 Adenocarcinoma of Lung 7 Recurrence 6 Fallopian Tube Neoplasms 6 Carcinoma, Ovarian Epithelial 6 Adenocarcinoma Of Esophagus 6 Carcinoma, Squamous Cell 5 Carcinoma 5 Inflammatory Breast Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Breast Neoplasms, Male 4 Advanced Solid Tumors 4 Adenocarcinoma 4 Urethral Neoplasms 3

Interventions

Nivolumab 6 linrodostat 3 relatlimab 2 Pemetrexed 2 Ipilimumab 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡